Crestchem Limited has notified BSE Limited of an upcoming Board of Directors meeting scheduled for Tuesday, May 26, 2026, at 12:15 Noon, pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meeting will address several significant corporate matters, including the approval of audited financial results for the quarter and financial year ended March 31, 2026, and a recommendation on final dividend.

Key Agenda Items

The board meeting has been convened to deliberate on a broad range of items. The following table summarises the primary agenda points:

Subsidiary Incorporation and Investment

The board will take note of the formation of Oleo Biosciences Private Limited, incorporated on March 31, 2026, and based in Bangalore, Karnataka, bearing CIN No. U20110KA2026PTC218609. The company has not commenced any activity during the financial year ended 2026. Additionally, the board will consider an investment of up to ₹2.25 Crores in the subsidiary under Sections 179 and 186 of the Companies Act, 2013, through permissible means including loans, intercorporate loans, or equity share capital.

Managerial Appointments and Reappointments

The board will consider the reappointment of Mr. Dipak Narendraprasad Patel for a period of five years from October 1, 2026 to September 30, 2031. Similarly, the reappointment of Mrs. Parul Dipak Patel for five years from October 1, 2026 to September 30, 2031, will be considered under Section 188 of the Companies Act, 2013. The appointment of Mrs. Tansi Nirmite Patel for a five-year term from April 1, 2026 to March 31, 2031, under Section 188 of the Companies Act, 2013, is also on the agenda.

Trading Window Closure

In accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code for prohibition of insider trading, the trading window for dealing in the securities of the company for directors, officers, key managerial personnel, and designated persons has been closed from April 1, 2026 and will remain closed until 48 hours after the financial results are made public following the said meeting.

The intimation was submitted by Nitin S. Shah, Company Secretary and Compliance Officer (ACS-7088), on behalf of Crestchem Limited, dated May 18, 2026.

Crestchem Limited has disclosed under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 that its subsidiary, Oleo Biosciences Private Limited, has successfully completed the filing of Form INC-20A (Declaration for Commencement of Business) with the Registrar of Companies and has accordingly commenced its business operations. The disclosure was made on May 7, 2026, from Ahmedabad, signed by Company Secretary & Compliance Officer Nitin S. Shah. The subsidiary is now in the process of initiating activities related to the establishment of a pilot plant and product development machineries at Bangalore, Karnataka.

Subsidiary Formation and Shareholding Structure

Oleo Biosciences Private Limited was incorporated as a new entity under the Companies Act, 2013, with Crestchem Limited holding a 75% stake and a minority promoter holding the remaining 25%. The subsidiary was established with an initial authorized and paid-up capital of Rs.10,00,000/-, with Crestchem subscribing to 75,000 equity shares at Rs.10/- each, representing a total investment of Rs.7,50,000/-. The following table summarises the key shareholding and investment details:

Business Objectives and Regulatory Details

The subsidiary has been formed with the primary objective of establishing a pilot plant and machineries for the manufacture of oleo chemicals, which are speciality chemicals and related products, to cater to existing and potential customers in southern India. The disclosure provides the following details as required under the SEBI Circular dated July 13, 2023:

Management and Compliance

Mr. Dipak Narendraprasad Patel, Managing Director of Crestchem Limited, has been appointed as Director of Oleo Biosciences Private Limited to strategically oversee the subsidiary's affairs. Day-to-day operational and management responsibilities will be handled by local onsite management personnel stationed in Bangalore. The board had also authorised Mr. Patel to sign all related documents and perform necessary acts for the subsidiary's business operations. A rental agreement has been executed to acquire a shed for installing the pilot plant, machinery, laboratory, and product development equipment, and investment matters have been addressed under Sections 179 and 186 of the Companies Act, 2013, ensuring compliance with prescribed limits and applicable provisions.